F279-0302 Screening compound: N-(4-fluorophenyl)-2-[4-(4-methoxyphenyl)-3-methyl-7-oxo-6H,7H-[1,2]oxazolo[3,4-d]pyridazin-6-yl]propanamide

F279-0302 Screening compound: N-(4-fluorophenyl)-2-[4-(4-methoxyphenyl)-3-methyl-7-oxo-6H,7H-[1,2]oxazolo[3,4-d]pyridazin-6-yl]propanamide
F279-0302 Screening compound: N-(4-fluorophenyl)-2-[4-(4-methoxyphenyl)-3-methyl-7-oxo-6H,7H-[1,2]oxazolo[3,4-d]pyridazin-6-yl]propanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F279-0302
N-(4-fluorophenyl)-2-[4-(4-methoxyphenyl)-3-methyl-7-oxo-6H,7H-[1,2]oxazolo[3,4-d]pyridazin-6-yl]propanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F279-0302

Molecular Formula

C22H19FN4O4 (C22 H19 FN4 O4)

Compound Name

N-(4-fluorophenyl)-2-[4-(4-methoxyphenyl)-3-methyl-7-oxo-6H,7H-[1,2]oxazolo[3,4-d]pyridazin-6-yl]propanamide

IUPAC name

N-(4-fluorophenyl)-2-[4-(4-methoxyphenyl)-3-methyl-7-oxo-6H7H-[12]oxazolo[34-d]pyridazin-6-yl]propanamide

SMILES

CC(C(Nc(cc1)ccc1F)=O)N(C(c1noc(C)c11)=O)N=C1c(cc1)ccc1OC

InChI

InChI=1S/C22H19FN4O4/c1-12(21(28)24-16-8-6-15(23)7-9-16)27-22(29)20-18(13(2)31-26-20)19(25-27)14-4-10-17(30-3)11-5-14/h4-12H,1-3H3,(H,24,28)/t12-/m0/s1

InChI Key

LSDJONBJPAYPNG-LBPRGKRZSA-N

MDL Number (MFCD)

MFCD27111377

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

422.42

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

2.978

Distribution Coefficient, logD

2.978

Water Solubility, LogSw

-3.55

Polar Surface Area

78.957

Acid Dissociation Constant (pKa)

11.15

Base Dissociation Constant (pKb)

0.97

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

18.20

F279-0302 in Drug Discovery

Included in Screening Libraries

GABA Library (7115 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Eye
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • GPCR
  • Ion Channels
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • Receptor's ligands

References: we are preparing a list of scientific research reports with F279-0302 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F279-0302?
Check Price and Availability of F279-0302, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F279-0302 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F279-0302
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F279-0302
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F279-0302 available by request